User
Notification
Business Standard

Don’t miss the latest developments in business and finance.

Pharmaceutical

The acquisition is expected to be completed before March 7, 2025, subject to approval from the Ontario Superior Court of Justice

Updated On: 16 Jan 2025 | 11:30 PM IST
Bs_logoSun Pharma's unit Taro to acquire 100% stake in Antibe Therapeutics

PAG had earlier acquired Manjushree Technopack for $1bn

Updated On: 13 Jan 2025 | 10:02 PM IST
Bs_logoPAG acquires majority stake in Pravesha Industries for $200 million

These granules, available in 25 mg, 50 mg, and 75 mg per unit dose packets, are a generic equivalent of Kalydeco Oral Granules

Updated On: 09 Jan 2025 | 6:47 PM IST
Bs_logoLupin receives US FDA tentative approval for Ivacaftor Oral Granules

Lupin, headquartered in Mumbai, India, is a global pharmaceutical player with products distributed in over 100 markets

Updated On: 08 Jan 2025 | 7:34 PM IST
Bs_logoLupin gets clearance from USFDA for its Pithampur manufacturing facility

These systems can be deployed across various industries ranging from pharmaceuticals, and consumer goods to the automotive sector

Updated On: 05 Jan 2025 | 9:39 PM IST
Bs_logoAssembly lines adopt flexible robotics to meet rising consumer expectations

Among other demands is the removal of Section 194R, related to marketing samples, which would ease business operations

Updated On: 03 Jan 2025 | 11:21 PM IST
Bs_logoBudget wishlist: Pharma firms seek simplified taxes, stronger PLI scheme

Krishan Kumar Aurora, chairman emeritus of Pharmed Limited and BioPlus Group, passed away on December 23 at 88. He began his career in 1961 with Smith Kline & French, rising to VP for Southeast Asia

Updated On: 26 Dec 2024 | 12:08 PM IST

According to Bloomberg, 30 of 41 analysts are bullish on Sun Pharma, while the remaining seven have a neutral rating and only 4 are bearish

Updated On: 20 Dec 2024 | 11:56 PM IST

Brokerages slash target price after subdued Q2 show

Updated On: 30 Oct 2024 | 11:46 PM IST

Move comes after drug regulator had suspended nod granted to firm to manufacture, sell PresVu eye drops

Updated On: 26 Sep 2024 | 2:53 PM IST

The sector is expected to benefit from steady cash flows and low financial leverage, which will help maintain stable credit profiles, even as pharma cos pursue acquisitions in niche therapeutic areas

Updated On: 18 Sep 2024 | 4:59 PM IST

Akums Drugs and Pharmaceuticals on Friday said it has received patent for a formulation for Sickle Cell Disease (SCD). The company has received a patent from India patent office for its room temperature stable oral suspension of Hydroxyurea, a formulation aimed at managing SCD. "Our constant endeavor is to work on affordable medicines for Orphan Drugs and reduce dependency on imported medicines ensuring patient safety from rare diseases with timely and necessary treatment," Akums Managing Director Sanjeev Jain said in a statement. SCD, a genetic blood disorder, leads to severe health complications such as anaemia, frequent pain episodes and other debilitating symptoms, affecting millions worldwide, especially in India and Africa. Akums said its formulation will come at a fraction of the cost of imported Hydroxyurea solution.

Updated On: 13 Sep 2024 | 8:25 PM IST

The drug formulations market in India is expected to grow at a CAGR of 9-10 per cent over the next decade with Jan Aushadhi outlets anticipated to emerge as a much stronger player in the country, according to Glenmark Pharmaceuticals. The domestic formulations market is estimated to be at Rs 2 lakh crore, with a growth rate of 11 per cent over the past two decades. "It is projected that the domestic formulations market will maintain a compound annual growth rate (CAGR) of 9-10 per cent over the next decade," the Mumbai-based drug maker said in its Annual Report for 2023-24. As the Trade Generics and Jan Aushadhi channels expand, it is anticipated that these channels could collectively contribute 30 per cent to the market volume in ten years, it stated. The Jan Aushadhi initiative aims to enhance access to cost-effective, unbranded generics by scaling up to 25,000 franchise pharmacies by 2026, it said. "It is estimated that Jan Aushadhi procurement could account for 3-5 per cent o

Updated On: 08 Sep 2024 | 11:37 AM IST

The company further mentioned that the opinions and claims printed in news stories do not represent Entod Pharmaceuticals

Updated On: 06 Sep 2024 | 9:52 AM IST

Shares of Shilpa Medicare were trading at Rs 733.15, up by nearly Rs 36, or 5.15 per cent on the BSE. In contrast, the 30-stock BSE Sensex was trading at 81,714 levels, up 0.77 per cent.

Updated On: 26 Aug 2024 | 12:42 PM IST

Neffy's approval is based on 4 studies in 175 healthy adults without anaphylaxis that measured epinephrine concentrations in blood following administration of neffy

Updated On: 09 Aug 2024 | 10:39 PM IST

GSK Pharma's stocks were up by 2.49 per cent, ending the day's trade at Rs 2,824.45 apiece on the Bombay Stock Exchange (BSE)

Updated On: 02 Aug 2024 | 8:42 PM IST

Pharmaceutical industry is urging government to halt the transfer of nutraceutical oversight from FSSAI to the drug regulatory authority, citing potential market impact

Updated On: 17 Jul 2024 | 1:20 PM IST

Indian pharmaceutical companies recently came under the scanner after global supplies of certain medicines were found to be toxic

Updated On: 03 Jul 2024 | 11:36 AM IST